UK’s NICE requests additional information from Sanofi on effectiveness of MS drug

LONDON (Reuters) - Britain's healthcare cost watchdog wants more information from Sanofi on the effectiveness of its new multiple sclerosis pill Aubagio before deciding if it should be used on the sta…
Read the full story: MedCity News